# DCXR

## Overview
The DCXR gene encodes the enzyme dicarbonyl and L-xylulose reductase, a member of the short-chain dehydrogenase/reductase (SDR) superfamily. This enzyme is primarily involved in carbohydrate metabolism, where it plays a critical role in the reduction of L-xylulose to xylitol, contributing to the uronate cycle and detoxification of reactive carbonyl compounds. The enzyme's activity is essential for preventing the formation of harmful advanced glycation end-products (AGEs) and is implicated in cellular osmoregulation and protection against oxidative stress. Structurally, DCXR functions as a homotetramer and is highly expressed in the liver and kidney. Its expression levels and localization have been linked to various pathological conditions, including cancers, where it may serve as a biomarker or prognostic indicator depending on the cancer type (qing2024biological; MacWilliams2020AcDCXR; ChoVega2007DicarbonyllXylulose).

## Structure
The human dicarbonyl and L-xylulose reductase (DCXR) is a protein encoded by the DCXR gene, located on chromosome 17q25.3. The enzyme is a member of the short-chain dehydrogenase/reductase (SDR) superfamily and consists of a 25.7-kDa polypeptide chain comprising 244 amino acids (Hu2013(−)Epigallocatechin3gallate page 0 of 3). DCXR functions as a homotetramer, meaning it forms a quaternary structure composed of four identical subunits (Hu2013(−)Epigallocatechin3gallate page 0 of 3).

The enzyme's structure includes specific domains that facilitate its role in reducing sugars and dicarbonyl compounds. The active site of DCXR is crucial for its enzymatic activity, and molecular docking studies have identified key interactions within this site. For instance, (−)-epigallocatechin-3-gallate (EGCG), a potential inhibitor, forms hydrogen bonds with the Thr190 residue, highlighting the importance of this residue in the enzyme's function (Hu2013(−)Epigallocatechin3gallate page 0 of 3).

Post-translational modifications and alternative splicing may lead to different isoforms of DCXR, although specific details on these aspects are not provided in the available context. The enzyme is highly expressed in the liver and kidney, where it plays significant roles in detoxification, glucose metabolism, and osmoregulation (Hu2013(−)Epigallocatechin3gallate page 0 of 3).

## Function
The DCXR gene encodes the enzyme dicarbonyl and L-xylulose reductase, which plays a crucial role in carbohydrate metabolism. In healthy human cells, DCXR is involved in the reduction of L-xylulose to xylitol, a process that is part of the uronate cycle. This cycle is important for detoxifying reactive carbonyl compounds, which can otherwise form harmful advanced glycation end-products (AGEs) by reacting with amino acids such as lysine, cysteine, and arginine (MacWilliams2020AcDCXR).

DCXR is an oxidoreductase enzyme that participates in the metabolism of monosaccharides and dicarbonyls. It catalyzes reactions with sugars like xylitol, converting them to xylulose, which can then enter the pentose phosphate pathway. This pathway generates glycolytic intermediates that are used for energy production (MacWilliams2020AcDCXR). The enzyme is active in the cytoplasm, where it contributes to cellular osmoregulation and provides protection against oxidative stress by metabolizing harmful carbonyls (MacWilliams2020AcDCXR).

In humans, DCXR was initially identified in the context of pentosuria, a condition characterized by excessive excretion of L-xylulose due to an enzymatic defect in DCXR (MacWilliams2020AcDCXR).

## Clinical Significance
Alterations in the expression of the DCXR gene have been associated with various cancers. In prostate cancer, DCXR is significantly up-regulated, with expression levels two to eight times higher in cancerous tissues compared to normal tissues. This overexpression is particularly pronounced in high-grade cancers, suggesting its potential as a biomarker for prostate cancer (ChoVega2007DicarbonyllXylulose). Similarly, DCXR expression is increased in melanomas compared to normal skin, with aberrant expression patterns linked to malignant progression. In melanocytic lesions, a shift from membranous to cytoplasmic localization of DCXR is associated with decreased cell adhesion, potentially contributing to the invasive behavior of melanoma cells (Cho‐Vega2007Expression).

In contrast, DCXR expression is down-regulated in clear cell renal cell carcinoma (ccRCC), with lower levels observed in tumor tissues compared to adjacent normal tissues. This down-regulation is correlated with reduced proliferation and migration activities in renal cancer cell lines, indicating a potential role in inhibiting tumor growth and metastasis. The expression of DCXR in ccRCC is also linked to patient prognosis, suggesting its utility as a prognostic marker (qing2024biological). These findings highlight the complex role of DCXR in cancer, where its expression can either promote or inhibit tumor progression depending on the cancer type.


## References


[1. (Cho‐Vega2007Expression) Jeong Hee Cho‐Vega, Francisco Vega, Mary R. Schwartz, and Victor G. Prieto. Expression of dicarbonyl/<scp>l</scp>‐xylulose reductase (dcxr) in human skin and melanocytic lesions: morphological studies supporting cell adhesion function of dcxr. Journal of Cutaneous Pathology, 34(7):535–542, June 2007. URL: http://dx.doi.org/10.1111/j.1600-0560.2006.00661.x, doi:10.1111/j.1600-0560.2006.00661.x. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/j.1600-0560.2006.00661.x)

2. (qing2024biological) OUYANG Qing, ZHENG Bin, WU Shengpan, WANG Jichen, WANG Lei, LI Xiubin, and MA Xin. Biological function and potential mechanism of dicarbonyl and l-xylulose reductase in the occurrence and development of renal cell carcinoma. J Clin Urol, 39(4):314–320, 2024. This article has 0 citations.

[3. (MacWilliams2020AcDCXR) Jacob R. MacWilliams, Stephanie Dingwall, Quentin Chesnais, Akiko Sugio, and Isgouhi Kaloshian. Acdcxr is a cowpea aphid effector with putative roles in altering host immunity and physiology. Frontiers in Plant Science, May 2020. URL: http://dx.doi.org/10.3389/fpls.2020.00605, doi:10.3389/fpls.2020.00605. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fpls.2020.00605)

[4. (ChoVega2007DicarbonyllXylulose) Jeong Hee Cho-Vega, Spiridon Tsavachidis, Kim-Anh Do, Junichi Nakagawa, L. Jeffrey Medeiros, and Timothy J. McDonnell. Dicarbonyl/<scp>l</scp>-xylulose reductase: a potential biomarker identified by laser-capture microdissection-micro serial analysis of gene expression of human prostate adenocarcinoma. Cancer Epidemiology, Biomarkers &amp; Prevention, 16(12):2615–2622, December 2007. URL: http://dx.doi.org/10.1158/1055-9965.epi-07-0684, doi:10.1158/1055-9965.epi-07-0684. This article has 22 citations.](https://doi.org/10.1158/1055-9965.epi-07-0684)